Cigna Corporation
NYSE:CIMedical - Healthcare Plans
-$4.44 today
- Market cap
- $71.38B
- Beta
- 0.30
- P/E (TTM)
- 11.7
- EPS (TTM)
- $23.95
- Dividend yield
- 2.19%
Volume 2.62M
Average 1.61M
Returns on capital
Cigna Corporation management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
14.3%
avg 12.9%
ROIC
7.4%
avg 6.4%
ROA
3.8%
avg 3.5%
Analysis
ROE is currently the strongest return metric at 14.3% versus its period average of 12.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
David Michael Cordani | Executive Chairman of the Board | USD 5.44M | 61 | — | — |
Brian C. Evanko | President, CEO & Director | USD 3.28M | 49 | 6.72K | <0.01% |
Nicole Susan Jones | Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer | USD 2.03M | 55 | — | — |
Ann Dennison | Executive Vice President & Chief Financial Officer | USD 1.88M | 55 | — | — |
Durga Prasad Koka | Executive Vice President & Global Chief Information Officer | USD 1.88M | — | 1.36K | <0.01% |
F. Everett Neville | Executive VP & Special Advisor to the CEO | USD 1.84M | 61 | — | — |
Phil Austin | Head of Strategy & Global Business Development for Cigna International Markets | — | — | — | — |
Ralph Giacobbe | Senior Vice President of Investor Relations | — | — | — | — |
Andrea Nelson | EVP, General Counsel & Corporate Secretary | — | — | — | — |
Jamie Kates | Senior VP & Tax and Global Chief Accounting Officer | — | 46 | — | — |
Melissa Skottegaard | Executive Vice President, Chief Marketing & Communications Officer | — | — | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Sep 1, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
19
$66.84M
Net Transaction Value
−$66.84M
Net selling
Most Active
Cordani David
13 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Sep 3, 26Sep 3, 2026 | Neville Everett Direct | Sell | $175.3K$175,258.85 |
| Aug 18, 26Aug 18, 2026 | Jones Nicole S Direct | Sell | $748.5K$748,515.97 |
| Aug 4, 26Aug 4, 2026 | Jones Nicole S Direct | Sell | $5.4M$5,369,583.72 |
| Jun 12, 26Jun 12, 2026 | Kates Jamie G Direct | Sell | $268.5K$268,452.19 |
| May 12, 26May 12, 2026 | Cordani David Direct | Sell | $4M$3,996,088.90 |
| May 12, 26May 12, 2026 | Cordani David Direct | Sell | $1.1M$1,119,505.30 |
| May 12, 26May 12, 2026 | Cordani David Direct | Sell | $4.1M$4,115,590.06 |
| May 12, 26May 12, 2026 | Cordani David Direct | Sell | $4M$3,997,456.04 |
| May 12, 26May 12, 2026 | Cordani David Direct | Sell | $11.9M$11,918,783.98 |
| May 12, 26May 12, 2026 | Cordani David Direct | Sell | $3.6M$3,595,313.76 |
1–10 of 19
Summary
Insiders reported 0 buys worth $0.00 and 19 sells worth $66.84M over the last 12 months. That adds up to net selling of $66.84M. Cordani David was the most active insider with 13 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +1.2% | +14.8% (5yr)4 analysts |
| Revenue | N/A | N/A | +15.1% | +4.9% (5yr)14 analysts |
| Net Income | N/A | N/A | -3.9% | +14.5% (5yr)14 analysts |
| EBIT | N/A | N/A | +2.6% | +12.2% (5yr)14 analysts |
Analysis
Recent growth has been strongest in Revenue at +15.1% over three years. Forward estimates point to EPS at +14.8% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Cigna Corporation compete with?
Open similar companies to compare how their management teams allocate capital.
Questions
Management questions
Common questions about CI's management, answered from reported figures.
Who manages CI?
Cigna Corporation (CI) lists 11 active executives. The top listed executive is Brian C. Evanko, President, CEO & Director.
Are CI insiders buying or selling?
Recent insider activity shows net selling of $53.89M.
Continue the stock analysis
Jump to another research area for this company.